ABBOTT FDA Approval ANDA 085513

ANDA 085513

ABBOTT

FDA Drug Application

Application #085513

Application Sponsors

ANDA 085513ABBOTT

Marketing Status

Discontinued001

Application Products

001CAPSULE;ORAL25MG0A-POXIDECHLORDIAZEPOXIDE HYDROCHLORIDE

FDA Submissions

ORIG1AP1977-06-30
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1984-01-25

Submissions Property Types

SUPPL9Null0

CDER Filings

ABBOTT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 85513
            [companyName] => ABBOTT
            [docInserts] => ["",""]
            [products] => [{"drugName":"A-POXIDE","activeIngredients":"CHLORDIAZEPOXIDE HYDROCHLORIDE","strength":"25MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"A-POXIDE","submission":"CHLORDIAZEPOXIDE HYDROCHLORIDE","actionType":"25MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.